Pharmaceuticals company Ipca Laboratories announced Q2FY26 results Consolidated Net total Income up 9% at Rs 2,584.36 crore. Consolidated EBITDA margin (before forex (gain)/loss, other income and exceptional items) @ 21.68% in Q2FY26 as against @ 19.10% in Q2FY25. Consolidated Net Profit at Rs 282.57 crore (after exceptional items) up 23%. Exports Income up 7% at Rs 813.65 crore. Indian formulations income up 8% at Rs 1018.90 crore. Result PDF